• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝微粒体对苦参酮的代谢及其对细胞毒性的影响。

Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity.

作者信息

Zhang Xiuwen, Jiang Peng, Chen Ping, Cheng Nengneng

机构信息

a Department of Pharmacology , School of Pharmacy, Fudan University , Shanghai , China.

出版信息

Pharm Biol. 2016;54(4):619-27. doi: 10.3109/13880209.2015.1070876. Epub 2015 Oct 1.

DOI:10.3109/13880209.2015.1070876
PMID:26429409
Abstract

CONTEXT

Kurarinone, the most abundant prenylated flavonoid in Sophora flavescens Aiton (Leguminosae), is a promising antitumor therapeutic. However, it shows significant hepatotoxicity. Furthermore, how kurarinone is metabolized in humans remains unclear.

OBJECTIVE

The objective of this study is to investigate kurarinone metabolism in human liver microsomes (HLMs) and the role of metabolism in kurarinone-induced cytotoxicity.

MATERIALS AND METHODS

The UDP-glucuronosyltransferase isoforms (UGTs) involved in kurarinone glucuronidation were identified using chemical inhibitors (100-1000 µM phenylbutazone; 10-100 µM β-estradiol; 10-100 µM 1-naphthol; 10-500 µM propofol; and 100-1000 µM fluconazole) and recombinant human UGTs. Kurarinone (2-500 µM) was incubated with HLMs and UGTs (0.5 mg/mL) for 15 min to determine enzyme kinetic parameters. The IC50 value of kurarinone (10-200 µM) was evaluated in a HLMs/3T3 cell co-culture system.

RESULTS

Kurarinone is extensively converted to two glucuronides (M3 and M4) in HLMs. M3 formation was catalyzed by multiple UGT1As, with UGT1A3 showing the highest intrinsic clearance (120.60 mL/min/mg). M4 formation was catalyzed by UGT1A1, UGT2B4, and UGT2B7. UGT1A1 showed the highest intrinsic clearance (60.61 mL/min/mg). The kinetic profiles of the five main UGTs and HLMs fit substrate inhibition kinetics, with Km values ranging from 5.20 to 46.52 µM, Vmax values ranging from 0.20 to 3.06 µmol/min/mg, and Ksi values ranging from 25.58 to 230.30 µM. The kurarinone IC50 value was 93 μM in the control group, 102 μM in HLMs with NADPH, and 160 μM in HLMs with UDPGA.

DISCUSSION AND CONCLUSION

Kurarinone glucuronidation is a detoxification pathway. This information may help to elucidate the risk factors regulating kurarinone toxicity.

摘要

背景

苦参素是苦参(豆科)中含量最丰富的异戊烯基黄酮,是一种有前景的抗肿瘤治疗药物。然而,它具有显著的肝毒性。此外,苦参素在人体内的代谢方式仍不清楚。

目的

本研究旨在研究苦参素在人肝微粒体(HLMs)中的代谢情况以及代谢在苦参素诱导的细胞毒性中的作用。

材料与方法

使用化学抑制剂(100 - 1000 μM保泰松;10 - 100 μMβ-雌二醇;10 - 100 μM 1 - 萘酚;10 - 500 μM丙泊酚;100 - 1000 μM氟康唑)和重组人尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)鉴定参与苦参素葡萄糖醛酸化的UGT同工酶。将苦参素(2 - 500 μM)与HLMs和UGTs(0.5 mg/mL)孵育15分钟以确定酶动力学参数。在HLMs/3T3细胞共培养系统中评估苦参素(10 - 200 μM)的半数抑制浓度(IC50)值。

结果

苦参素在HLMs中广泛转化为两种葡萄糖醛酸苷(M3和M4)。M3的形成由多种UGT1A催化,其中UGT1A3显示出最高的内在清除率(120.60 mL/min/mg)。M4的形成由UGT1A1、UGT2B4和UGT2B7催化。UGT1A1显示出最高的内在清除率(60.61 mL/min/mg)。五种主要UGT和HLMs的动力学曲线符合底物抑制动力学,米氏常数(Km)值范围为5.20至46.52 μM,最大反应速度(Vmax)值范围为0.20至3.06 μmol/min/mg,底物抑制常数(Ksi)值范围为25.58至230.30 μM。对照组中苦参素的IC50值为93 μM,添加烟酰胺腺嘌呤二核苷酸磷酸(NADPH)的HLMs中为102 μM,添加尿苷二磷酸葡萄糖醛酸(UDPGA)的HLMs中为160 μM。

讨论与结论

苦参素葡萄糖醛酸化是一条解毒途径。这些信息可能有助于阐明调节苦参素毒性的危险因素。

相似文献

1
Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity.人肝微粒体对苦参酮的代谢及其对细胞毒性的影响。
Pharm Biol. 2016;54(4):619-27. doi: 10.3109/13880209.2015.1070876. Epub 2015 Oct 1.
2
Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.负责岩白菜素体外葡萄糖醛酸化的人尿苷二磷酸葡萄糖醛酸基转移酶的鉴定与表征
Biomed Chromatogr. 2014 Mar;28(3):348-53. doi: 10.1002/bmc.3027. Epub 2013 Sep 2.
3
UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.尿苷二磷酸葡萄糖醛酸基转移酶1A1是负责依托泊苷在人肝脏和肠道微粒体中进行葡萄糖醛酸化的主要酶:依托泊苷酚类和醇类葡萄糖醛酸苷的结构表征及酶动力学估算
Drug Metab Dispos. 2007 Mar;35(3):371-80. doi: 10.1124/dmd.106.012732. Epub 2006 Dec 6.
4
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.鉴定人肝脏中负责氟尼辛葡糖醛酸化的人尿苷二磷酸葡萄糖醛酸基转移酶。
Pharm Res. 2006 Jul;23(7):1502-8. doi: 10.1007/s11095-006-0250-5. Epub 2006 Jun 21.
5
Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.参与双酚A葡萄糖醛酸化的人类UDP-葡萄糖醛酸基转移酶同工型。
Chemosphere. 2008 Dec;74(1):33-6. doi: 10.1016/j.chemosphere.2008.09.053. Epub 2008 Nov 5.
6
Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.依达拉奉在人肝微粒体和肾微粒体中的葡萄糖醛酸化:双相动力学及 UGT1A9 为主要的 UDP-葡萄糖醛酸基转移酶同工酶的鉴定。
Drug Metab Dispos. 2012 Apr;40(4):734-41. doi: 10.1124/dmd.111.043356. Epub 2012 Jan 11.
7
The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.UDP-葡糖醛酸基转移酶2B7同工酶负责在人肝脏中对吉非贝齐进行葡糖醛酸化。
Drug Metab Dispos. 2007 Nov;35(11):2040-4. doi: 10.1124/dmd.107.017269. Epub 2007 Aug 1.
8
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.UDP对UDP-葡萄糖醛酸基转移酶(UGT)的产物抑制作用掩盖了UGT底物的抑制效果。
Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12.
9
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.尿苷二磷酸葡萄糖醛酸基转移酶2B7在人肝脏中对消旋氟比洛芬葡萄糖醛酸化的主要贡献。
Drug Metab Dispos. 2007 Jul;35(7):1182-7. doi: 10.1124/dmd.107.015347. Epub 2007 Apr 19.
10
Identification of Uridine 5'-Diphosphate-Glucuronosyltransferases Responsible for the Glucuronidation of Mirabegron, a Potent and Selective β-Adrenoceptor Agonist, in Human Liver Microsomes.在人肝微粒体中鉴定负责强效选择性β-肾上腺素能受体激动剂米拉贝隆葡萄糖醛酸化的尿苷5'-二磷酸葡萄糖醛酸转移酶。
Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):301-309. doi: 10.1007/s13318-017-0450-x.

引用本文的文献

1
and Characterization of Kurarinone as a Dopamine D Receptor Antagonist and D and D Receptor Agonist.苦参醌作为多巴胺D受体拮抗剂以及D和D受体激动剂的表征
ACS Omega. 2021 Dec 6;6(49):33443-33453. doi: 10.1021/acsomega.1c04109. eCollection 2021 Dec 14.
2
Five-Decade Update on Chemopreventive and Other Pharmacological Potential of Kurarinone: a Natural Flavanone.苦参黄酮的化学预防及其他药理潜力:五十年回顾——一种天然黄酮
Front Pharmacol. 2021 Sep 27;12:737137. doi: 10.3389/fphar.2021.737137. eCollection 2021.
3
An In Vitro Study for Evaluating Permeability and Metabolism of Kurarinone.
刺芒柄花素渗透性与代谢的体外评价研究
Evid Based Complement Alternat Med. 2020 Sep 13;2020:5267684. doi: 10.1155/2020/5267684. eCollection 2020.
4
Kurarinone from Roots Triggers ATF4 Activation and Cytostatic Effects Through PERK Phosphorylation.槐定碱通过 PERK 磷酸化触发 ATF4 激活和细胞生长停滞效应。
Molecules. 2019 Aug 27;24(17):3110. doi: 10.3390/molecules24173110.
5
Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats.苦参致肝毒性及其在大鼠体内苦参堿这一主要肝毒性成分的蓄积。
Molecules. 2017 Oct 25;22(11):1809. doi: 10.3390/molecules22111809.